News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
723,122 Results
Type
Article (42714)
Company Profile (295)
Press Release (680112)
Multimedia
Podcasts (85)
Webinars (13)
Section
Business (210536)
Career Advice (2093)
Deals (36658)
Drug Delivery (107)
Drug Development (83119)
Employer Resources (175)
FDA (16621)
Job Trends (15430)
News (356285)
Policy (33970)
Tag
Academia (2600)
Accelerated approval (7)
Adcomms (23)
Allergies (98)
Alliances (51540)
ALS (105)
Alzheimer's disease (1431)
Antibody-drug conjugate (ADC) (160)
Approvals (16616)
Artificial intelligence (311)
Autoimmune disease (27)
Automation (18)
Bankruptcy (372)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (116)
Biotechnology (188)
Bladder cancer (88)
Brain cancer (34)
Breast cancer (355)
Cancer (2754)
Cardiovascular disease (211)
Career advice (1754)
Career pathing (31)
CAR-T (179)
CDC (28)
Cell therapy (485)
Cervical cancer (22)
Clinical research (68143)
Collaboration (982)
Company closure (3)
Compensation (639)
Complete response letters (25)
COVID-19 (2687)
CRISPR (59)
C-suite (300)
Cystic fibrosis (113)
Data (2815)
Decentralized trials (2)
Denatured (29)
Depression (54)
Diabetes (309)
Diagnostics (6494)
Digital health (21)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (135)
Drug pricing (131)
Drug shortages (30)
Duchenne muscular dystrophy (118)
Earnings (89074)
Editorial (42)
Employer branding (21)
Employer resources (150)
Events (116450)
Executive appointments (848)
FDA (18173)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (888)
Gene editing (131)
Generative AI (23)
Gene therapy (372)
GLP-1 (792)
Government (4599)
Grass and pollen (5)
Guidances (180)
Healthcare (19019)
Huntington's disease (30)
IgA nephropathy (36)
Immunology and inflammation (144)
Immuno-oncology (7)
Indications (37)
Infectious disease (2841)
Inflammatory bowel disease (151)
Inflation Reduction Act (9)
Influenza (56)
Intellectual property (115)
Interviews (323)
IPO (16851)
IRA (50)
Job creations (4062)
Job search strategy (1492)
Kidney cancer (13)
Labor market (49)
Layoffs (509)
Leadership (18)
Legal (8394)
Liver cancer (79)
Lung cancer (386)
Lymphoma (195)
Machine learning (9)
Management (59)
Manufacturing (375)
MASH (86)
Medical device (13511)
Medtech (13516)
Mergers & acquisitions (20472)
Metabolic disorders (798)
Multiple sclerosis (94)
NASH (17)
Neurodegenerative disease (114)
Neuropsychiatric disorders (32)
Neuroscience (2092)
NextGen: Class of 2025 (6641)
Non-profit (4534)
Now hiring (46)
Obesity (416)
Opinion (239)
Ovarian cancer (95)
Pain (113)
Pancreatic cancer (111)
Parkinson's disease (180)
Partnered (22)
Patents (286)
Patient recruitment (139)
Peanut (52)
People (59570)
Pharmaceutical (91)
Pharmacy benefit managers (22)
Phase I (21149)
Phase II (29993)
Phase III (22449)
Pipeline (1565)
Policy (197)
Postmarket research (2654)
Preclinical (9019)
Press Release (68)
Prostate cancer (132)
Psychedelics (32)
Radiopharmaceuticals (257)
Rare diseases (454)
Real estate (6264)
Recruiting (67)
Regulatory (23347)
Reports (50)
Research institute (2372)
Resumes & cover letters (359)
Rett syndrome (9)
RNA editing (9)
RSV (45)
Schizophrenia (88)
Series A (152)
Series B (100)
Service/supplier (12)
Sickle cell disease (60)
Special edition (19)
Spinal muscular atrophy (150)
Sponsored (32)
Startups (3734)
State (2)
Stomach cancer (14)
Supply chain (73)
Tariffs (61)
The Weekly (54)
Vaccines (766)
Venture capital (48)
Weight loss (264)
Women's health (43)
Worklife (16)
Date
Today (114)
Last 7 days (532)
Last 30 days (2568)
Last 365 days (31927)
2025 (15462)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33137)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (782)
Alabama (59)
Alaska (7)
Arizona (249)
Arkansas (14)
Asia (41001)
Australia (6556)
California (7178)
Canada (2268)
China (652)
Colorado (305)
Connecticut (310)
Delaware (183)
Europe (87621)
Florida (1077)
Georgia (239)
Idaho (58)
Illinois (627)
India (27)
Indiana (357)
Iowa (16)
Japan (215)
Kansas (108)
Kentucky (27)
Louisiana (13)
Maine (64)
Maryland (1002)
Massachusetts (5376)
Michigan (242)
Minnesota (436)
Mississippi (3)
Missouri (85)
Montana (28)
Nebraska (25)
Nevada (77)
New Hampshire (66)
New Jersey (1996)
New Mexico (29)
New York (2021)
North Carolina (1067)
North Dakota (8)
Northern California (3155)
Ohio (227)
Oklahoma (15)
Oregon (39)
Pennsylvania (1563)
Puerto Rico (17)
Rhode Island (36)
South America (1163)
South Carolina (34)
South Dakota (1)
Southern California (2676)
Tennessee (120)
Texas (1071)
United States (26742)
Utah (213)
Virginia (184)
Washington D.C. (72)
Washington State (612)
West Virginia (4)
Wisconsin (66)
723,122 Results for "reviva pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Reviva to Participate in Upcoming Investor Conferences in May 2025
May 20, 2025
·
1 min read
Press Releases
Reviva to Participate in the Citizens Life Sciences Conference
April 30, 2025
·
1 min read
Press Releases
Reviva to Participate in the A.G.P. Healthcare Company Showcase
May 13, 2025
·
1 min read
Press Releases
Reviva to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
June 5, 2025
·
1 min read
Press Releases
Reviva Reports First Quarter 2025 Financial Results and Recent Business Highlights
May 15, 2025
·
8 min read
Press Releases
Reviva Announces Positive Full Dataset for 1-Year Phase 3 RECOVER Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
June 2, 2025
·
10 min read
Biotech Bay
Reviva to Participate in the BIO International Convention 2024
Reviva Pharmaceuticals Holdings, Inc. announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will participate in a panel discussion at the BIO International Convention, taking place June 3-6, 2024, in San Diego, CA.
May 21, 2024
·
1 min read
Press Releases
Reviva Reports Full Year 2024 Financial Results and Recent Business Highlights
April 1, 2025
·
9 min read
Biotech Bay
Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”) today announced that Laxminarayan Bhat, Ph.D., Founder, President, and CEO of Reviva will present at the 2024 BIO CEO & Investor Conference, taking place February 26-27, 2024, in New York, NY.
February 20, 2024
·
1 min read
Press Releases
Reviva to Participate in the 2025 BIO CEO & Investor Conference
January 30, 2025
·
1 min read
1 of 72,313
Next
